Antibody-drug conjugates - 15 News from the business & finance department for the pharma industry

Tip: You can further refine your news selection by organizations and countries.

Antibody-drug conjugates - 15 News from the business & finance department for the pharma industry

Tip: You can further refine your news selection by organizations and countries.

image description

Merck Reiterates Confidence in Returning to Sustainable Growth

Tailwind thanks to robust global growth trends in all three business sectors

18-Oct-2024 - Merck is looking confidently toward the future. At the Capital Markets Day, the company shared its expectation of profitable and financially strong growth in the coming years. After the transitional year of 2023, Merck considers the medium-term growth opportunities in its markets to be intact. ...

antibody-drug conjugates artificial intelligence cardiovascular diseases
image description

Tubulis closes upsized €128 million Series B2

"This substantial financing from a syndicate of global specialist biotech investors recognizes Tubulis’ unique position in the ADC space"

18-Mar-2024 - Tubulis announced the successful completion of an upsized and oversubscribed €128 million ($138.8 million) Series B2 financing. The round was co-led byEQT Life Sciences and Nextech Invest Ltd, on behalf of one or more funds managed by it, with participation from new US-based funds, Frazier Life ...

antibody-drug conjugates antibody-drug conjugate cancer
image description

Merck Strengthens Oncology Pipeline Through Strategic Partnership with Hengrui

Agreement represents strong strategic fit that leverages the company’s internal DNA damage response expertise and in-house ADC capabilities

02-Nov-2023 - Merck announced a strategic collaboration with Jiangsu Hengrui Pharmaceuticals Co. Ltd. (Hengrui). The partnership includes an exclusive license worldwide (ex-China) to develop, manufacture and commercialize Hengrui’s next-generation potent and selective PARP1 (poly (ADP-ribose) polymerase 1) ...

antibody-drug conjugates active ingredient candidates antibody-drug conjugate
image description

BioNTech and DualityBio form global strategic partnership

Focus on accelerated development of differentiated antibody-drug conjugates therapeutics for solid tumors

04-Apr-2023 - BioNTech SE and Duality Biologics (Suzhou) Co. Ltd. (DualityBio), a clinical-stage biotech company focusing on the discovery and development of next generation antibody-drug conjugate (“ADC”) therapeutics to treat patients with cancer and autoimmune diseases, announced that the companies have ...

antibody-drug conjugates antibody-drug conjugate cancer
image description

Lonza Completes Expansion of Conjugation Facility in Visp

Expansion adds development and manufacturing capacity for pre-clinical, clinical and commercial supply of bioconjugates and antibody-drug conjugates

20-Feb-2023 - Lonza announced that a planned expansion of its bioconjugation facility in Visp (CH) is complete. The expansion includes two manufacturing suites and supporting infrastructure. It will support an extended customer portfolio, including companies entering clinical development. The investment ...

antibody-drug conjugates antibody-drug conjugate bioconjugates
image description

Merck Announces Collaboration With Mersana Therapeutics to Develop Novel Immunostimulatory Antibody-Drug Conjugates

Mersana to receive $30 million upfront payment, up to $800 million in development, regulatory and commercial milestones, as well as royalties on net sales

27-Dec-2022 - Merck announced a research collaboration and commercial license agreement with Mersana Therapeutics, Inc., Cambridge, Massachusetts, USA to discover novel antibody-drug conjugates (ADCs) leveraging Mersana’s proprietary Immunosynthen STING-agonist ADC platform, directed against up to two targets. ...

antibody-drug conjugates antibody-drug conjugate immunotherapies
image description

Araris Biotech Closes $24 Million Financing Round

"Araris continues to make waves in the industry with its pioneering linker technology, enabling fast and precise production of ADCs"

10-Oct-2022 - Araris Biotech AG, a company pioneering a proprietary antibody-drug conjugate (ADC)-linker technology, announced the closing of a $24 million financing round, bringing the total funds raised to $40 million to date. The round was co-led by 4BIO Capital and Pureos Bioventures, with participation ...

antibody-drug conjugates antibody-drug conjugate financing
image description

Spirea raises £2.4M to develop antibody drug conjugates in cancer

Funding will enable the development of Spirea’s pipeline of antibody drug conjugate therapeutics for the treatment of solid tumours

21-Jun-2022 - Spirea Limited, a Cambridge company created to advance a new generation of antibody drug conjugate (ADC) therapeutics, has announced that it has secured funding of £2.4 million ($3M) with investments from high-profile UK and US investors. Spirea will use the funds to initiate its pipeline of ...

antibody-drug conjugates antibody-drug conjugate cancer
image description

Tubulis Closes €60 Million Series B Financing

Accelerate its ADC Pipeline and Expand its Breadth of Platform Technologies

05-May-2022 - Tubulis announced the successful completion of a €60 million (USD $63 million) Series B financing led by Andera Partners with participation from new investors Evotec and Fund+. All existing investors also participated in the round, including Bayern Kapital (with Wachstumsfonds Bayern 2), ...

antibody-drug conjugates antibody-drug conjugate cancer
image description

Emergence Therapeutics raises €87 million Series A financing

Lead product is a next-generation Nectin-4 ADC designed to increase efficacy and minimize toxicity

08-Dec-2021 - Emergence Therapeutics AG, a biopharmaceutical company developing novel antibody drug conjugates (ADC) for the treatment of cancers with high unmet needs, announces that it has closed an €87 million series A financing round. The round was led by Pontifax Venture Capital and includes RA Capital ...

antibody-drug conjugates antibody-drug conjugate bladder cancer
Search all
Haven't found the right news yet?

The bionity.com news search

Start your targeted search now with a wide range of filter options. Our database includes an archive of 27,220 life science news from business and science, which you can search by topic and organization, filtered by time and geography.

Start news search now